US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.29

-0.0639-0.10%

Volume:81

Turnover:5K

Market Cap:662.92K

PE:- -

High:66.29

Open:66.35

Low:66.29

Close:66.35

52wk High:85.03

52wk Low:61.00

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.24

T/O Rate:0.81%

Dividend:2.08

Dividend Rate:3.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.

Top Calls on Wall Street: Nvidia, Apple, Tesla, SpaceX, Boeing, Nokia, Humana and More

Tiger Newspress

GSK Falls Thursday, Underperforms Market

GSK CEO Sees Oncology Business as Underappreciated

Barclays Remains a Sell on GlaxoSmithKline (GSK)

Why Vaxcyte Chose A 1.5% Convertible

GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint

MT Newswires Live

GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement

GSK Slides Monday, Underperforms Market

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

GSK Slides Wednesday, Underperforms Market

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live

Jefferies Remains a Buy on GlaxoSmithKline (GSK)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/GSKH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":66.2858,"timestamp":1791576000000,"preClose":66.3497,"halted":0,"volume":81,"delay":0,"changeRate":-0.0009630789589101962,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Post-Mkt","change":-0.0639,"latestTime":"10-09 18:18:03 EDT","open":66.3497,"high":66.2858,"low":66.2858,"amount":5367,"amplitude":0,"askPrice":99.61,"askSize":200,"bidPrice":33.21,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":66.3497,"nav":67.023178,"aum":670298.803178,"dividendRate":0.031393,"bidAskSpread":0,"volumeRatio":0.242225,"impliedVol":0.3657,"impliedVolPercentile":0.985},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.242225,"shares":10001,"dividePrice":2.0809,"high":66.2858,"amplitude":0,"preClose":66.3497,"low":66.2858,"week52Low":61,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":66.2858,"eps":0,"divideRate":0.031393,"volume":81,"delay":0,"ttmEps":0,"open":66.3497,"prevYearClose":68.2031,"prevWeekClose":66.9733,"prevMonthClose":68.5811,"prevQuarterClose":68.5811,"fiveDayClose":66.9733,"twentyDayClose":66.9705,"sixtyDayClose":73.0646},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674986565","title":"Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.","url":"https://stock-news.laohu8.com/highlight/detail?id=2674986565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674986565?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563460,"startTime":"0","endTime":"0","summary":"There are several options for flu shots, including the first mRNA flu vaccine, which was developed by ModernaThere are several options for flu shots this year, including a new mRNA-based flu vaccine d","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2417539215.USD","AZN","BK4501","BK4568","BK4585","AZNH","GNOM","LU0109394709.USD","LU2089984988.USD","LU2456880835.USD","IE00BFXG1179.USD","LU0310800379.SGD","LU2462157665.USD","LU2237443465.HKD","SNY","IE00B3T34201.USD","LU0708994859.HKD","BK4551","IDNA","LU2237443978.SGD","LU1267930573.SGD","LU2237443382.USD","BK4139","GSK.UK","BK4533","MRNX","LU2237443895.HKD","LU0432979614.USD","BK4588","LU1829250122.USD","MRNA","GSKH","LU0889565916.HKD","LGHT","LU2237443622.USD","LU0029864427.USD","LU0289739699.SGD","GSK","LU2468319806.SGD","MRNY","BK4534","WDNA","LU2237443549.SGD","LU2236285917.USD","BK4532","BK4548","LU0058720904.USD","BK4007","LU0320765992.SGD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164439223","title":"Top Calls on Wall Street: Nvidia, Apple, Tesla, SpaceX, Boeing, Nokia, Humana and More","url":"https://stock-news.laohu8.com/highlight/detail?id=1164439223","media":"Tiger Newspress","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164439223?lang=en_us&edition=fundamental","pubTime":"2026-10-09 23:05","pubTimestamp":1791558346,"startTime":"0","endTime":"0","summary":"Here Are Friday’s Biggest Calls on Wall StreetUBS Reiterates Nvidia as BuyUBS maintained its Buy rating on Nvidia (NVDA), citing September Taiwan export data as evidence of strong AI demand.The firm...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS","CRSH","SNK","NVDA","AAPX","NVDY","SPAL","07766","NVDB","NVYY","BA","NVII","GSK","07788","ANV","SPAX","SPCH","07388","IOSX","AXP","07366","09366","TSL","SPCG","NVDD","SPCQ","SPCM","LOFD","AAPW","TSDD","NVDU","TSLA","TSLI","DIPS","NVDX","TSLG","TSLS","LOFF","SPCU","BOEU","NVDG","TSYY","TESL","TSLW","APLY","BOED","TSLO","NVDQ","TESC","TEST","NVDL","SPCF","TLA","TSLP","NVDW","AAPL","AAPE","TSLQ","BOEG","NVD","TSLZ","AAPB","09766","DSPC","NVDO","TSII","TSLY","TSLL","HUM","TSLT","AAPU","AAPD","AAPY","TSLR","GSKH","YSPC","ELOL","SPCX","FSLY","NVC","SSPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674524009","title":"GSK Falls Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2674524009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674524009?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:06","pubTimestamp":1791475560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  slid 3.07% to GBP17.36 Thursday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.16% to 10,441.60.GSK PLC closed 23.95% short of its 52-week high of GBP22.82, which the company reached on February 18th.Trading volume totaled 5.5 million, compared to the 50-day average of 5.9 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","BK4532","LU1829250122.USD","BK4588","GSK","GSK.UK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673539072","title":"GSK CEO Sees Oncology Business as Underappreciated","url":"https://stock-news.laohu8.com/highlight/detail?id=2673539072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673539072?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:08","pubTimestamp":1791461280,"startTime":"0","endTime":"0","summary":"1208 GMT - GSK CEO Luke Miels sees the U.K. drugmaker's oncology business as underappreciated by the market and expects upcoming updates at a medical congress to boost investors' confidence, J.P. Morgan analysts say, citing a recent call with Miels. \"[Miels] reiterated his confidence in delivering GSK's 2031 sales target of [more than 40 billion pounds], pointing to the breadth and depth of the portfolio, particularly in oncology, which [Miels] sees as underappreciated by consensus,\" the analysts say in a note. GSK expects to provide updates on its oncology portfolio at the annual congress of the European Society For Medical Oncology, which Miels expects will improve confidence in the pipeline, JPM says. Shares fall 1.8%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","BK4007","LU1829250122.USD","BK4532","BK4588","GSKH","BK4585","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673093774","title":"Barclays Remains a Sell on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673093774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673093774?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:45","pubTimestamp":1791355525,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £18.00. According to TipRanks, Gordon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK","GSK.UK","GSKH","BK4007","BK4585","BK4532","BK4588","CFA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179317192","title":"Why Vaxcyte Chose A 1.5% Convertible","url":"https://stock-news.laohu8.com/highlight/detail?id=1179317192","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179317192?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:39","pubTimestamp":1791355173,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3223.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","NVOH","SNY","ELIL","ABBV","ELIS","VERU","VIR","NVOC","GSKH","NVOX","LLY","PFE","NVAX","BMY","LLII","MRNY","GSK","NVS","AZN","GILD","LLYX","BNTX","MRNX","NVO","JNJ","MRNA","REGN","PCVX","BIIB","ABT","AMGN"],"isVideo":true,"video":{"duration":118,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3223.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","audio_url":"https://static.tigerbbs.com/a3b4d121da19466383da6687bb50a205.mp3","isAI":true},"gpt_icon":0},{"id":"2673054830","title":"GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054830","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673054830?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:42","pubTimestamp":1791294162,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, which is majority owned by GSK , said Tuesday that a phase 3b study has met its primary endpoint, showing that at six months, Cabenuva saw \"superior rates of viral suppression\" compared with oral antiretroviral therapy in adults and adolescents with HIV-1, who had detectable virus when they started the trial.The trial has enrolled 326 participants in eight countries at 85 study sites, the company said.The results follow a previous trial that showed that Cabenuva was superior to daily oral therapy in keeping viral suppression for people with HIV who had reached viral suppression on oral antiretroviral therapy but had a history of adherence challenges, ViiV said.The latest trial addressed a \"remaining evidence gap by evaluating direct initiation of the regimen in people who still had detectable virus at study entry,\" the company said.ViiV said the latest results will now be shared with health regulators.Price: 46.77, Change: +0.24, Percent Change: +0.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK","HCSG","GSK.UK","XBI","LU0029874061.USD","BK4137","GSKH","BK4007","BK4581","BK4585","LU1829250122.USD","BK4588","LABU","LU0128526141.USD","BK4532","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051943","title":"GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051943","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051943?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:10","pubTimestamp":1791292244,"startTime":"0","endTime":"0","summary":"ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), with Shionogi as a shareholder, announced the phase IIIb CROWN stud...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-announces-phase-iiib-crown-study-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","XLV","GSK.UK","GSKH","HCSG","LABU","BK4007","XBI","BK4585","LU0128526141.USD","LU0029874061.USD","BK4532","BK4137","BK4588","BK4581","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130787623","title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","url":"https://stock-news.laohu8.com/highlight/detail?id=1130787623","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130787623?lang=en_us&edition=fundamental","pubTime":"2026-10-06 10:42","pubTimestamp":1791254527,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3157.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","ELIL","REGN","NVOX","SNY","LLII","BIIB","ELIS","GSK","JNJ","NVAX","ABBV","NVO","SBIO","MRNX","AZN","NVS","PFE","NVOC","VIR","DNA","LLY","BNTX","IDNA","NVOH","ABT","MRNY","MRNA","VERU","XBI","AMGN","GERM","LLYX","MRK","GILD","GSKH"],"isVideo":true,"video":{"duration":153,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3157.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","audio_url":"https://static.tigerbbs.com/bf2704fcb2c9a829b788528d676b3500.mp3","isAI":true},"gpt_icon":0},{"id":"2673085761","title":"GSK Slides Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085761?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:09","pubTimestamp":1791216540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares dropped 1.15% to GBP17.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.34% to 10,497.94.GSK PLC closed 22.92% below its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 3.4 million, compared to the 50-day average of 6.4 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","GSK","GSKH","BK4007","BK4585","GSK.UK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673832210","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2673832210","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673832210?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:12","pubTimestamp":1791213166,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.14% to 1,883.96 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lender Banco Santander  and brewing company Anheuser-Busch InBev , which advanced 3.2% and 0.8% respectively. They were followed by 3D printer company Materialise  and internet browser company Opera , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Nokia  and biopharmaceutical company Cellectis , which lost 3.2% each. They were followed by biopharmaceutical company DBV Technologies  and petroleum refiner Equinor , which decreased 0.9% and 0.4%, respectively.The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics  and software firm Endava plc , which climbed 17% and 1.6% respectively. They were followed by medical device maker Smith & Nephew  and biotech firm Trinity Biotech","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSKH","BK4020","LFGY","DAVA","SNN","DBVT","AFG","IEUR","BK4546","EQNR","CLLS","SAN","IE00BMPRXR70.SGD","LU0006061336.USD","TRIB","BK4107","BK4158","BK7142","EPV","BK4201","PRNT","BK7119","LNOK","NOK","BUD.AU","BK4023","BK4082","BK4521","GSK.UK","IE00BMPRXN33.USD","IHG","BCYC","GSK","BK4547","OPRA","BK4134","BUD","SAN.AU","DAVA.AU","BK4142","BK4117","BK4588","SLN","BK4585","BDRX","LU0084288595.USD","LU1829250122.USD","MTLS","GSIB","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124786704","title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","url":"https://stock-news.laohu8.com/highlight/detail?id=1124786704","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124786704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:41","pubTimestamp":1791182489,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3135.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","SDOW","BNTX","MMAX","GSK","SPYH","DMAX",".IXIC","NVOH","SPYQ","TQQQ","SQQQ","ELIL","JPO","SNY","ELIS","NVOX","SH","VOO","MRNA","UDOW","NVOC","SPYM","LLII","HIBL","SPXU","LLYX",".SPX","SPXL","SSO","AZN","VIR","BMY","JPM","NVS","MRNY","DXD","SMAX","BIIB","DDM","NVO","REGN","YSPY","SPUU","LLY","ABT","GILD","SPY","SDS","JPMO","DIA","ABBV","IVV","NVAX","VERU","MRNX",".DJI","DOG","PFE","MRK","SPYU","SPDN","SPXS","JNJ","AMGN","UPRO","GSKH"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3135.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","audio_url":"https://static.tigerbbs.com/d492d9882b1cd5d0c5306026a8f1963f.mp3","isAI":true},"gpt_icon":0},{"id":"1157208455","title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157208455","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157208455?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:38","pubTimestamp":1791167898,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3125.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","GSK","AMGN","JNJ","BMY","LLY","NVAX","VIR","LLII","BNTX","ABT","AZN","NVOX","NVO","LLYX","REGN","VERU","ELIL","MRK","MRNY","PFE","ABBV","NVOC","MRNA","SNY","MRNX","BIIB","CSLLY","NVOH","GILD","GSKH","NVS"],"isVideo":true,"video":{"duration":229,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3125.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","audio_url":"https://static.tigerbbs.com/c84a44b957cb1cda4f39d165f739b07a.mp3","isAI":true},"gpt_icon":0},{"id":"1151971109","title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1151971109","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151971109?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:22","pubTimestamp":1791019366,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3081.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","AZN","MRNY","SNY","LLYX","MRK","GSK","NVS","MRNA","ABBV","NVOH","BAYRY","BNTX","ABT","BMY","GSKH","NVAX","REGN","ELIS","LLII","MRNX","NVO","NVOX","BIIB","NVOC","AMGN","ELIL","LLY","VIR","VERU","GILD","PFE"],"isVideo":true,"video":{"duration":206,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3081.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","audio_url":"https://static.tigerbbs.com/f1bbc2b54742b92aafc704bc4d0c576c.mp3","isAI":true},"gpt_icon":0},{"id":"1198460816","title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","url":"https://stock-news.laohu8.com/highlight/detail?id=1198460816","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198460816?lang=en_us&edition=fundamental","pubTime":"2026-10-03 16:06","pubTimestamp":1791014787,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3076.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","MRNY","ELIS","NVAX","AMGN","LLII","REGN","BIIB","BNTX","NVOH","ABT","BMY","JNJ","NVO","AZN","ABBV","SNY","NVOC","MRNA","VIR","NVS","MRNX","GSK","VERU","ELIL","LLY","GSKH","LLYX","MRK","GILD","PFE"],"isVideo":true,"video":{"duration":261,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3076.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","audio_url":"https://static.tigerbbs.com/5f9a45d52af3674e966786287f89b42c.mp3","isAI":true},"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BNTX","SNY","TEMC","RBOT","LLII","SBIO","DNA","ABT","TEMT","NVS","IDNA","JNJ","REGN","MRNY","NVOX","AMGN","LLY","GSK","MRNX","NVAX","GERM","GILD","LLYX","RXRX","TXG","ABSI","ELIL","GSKH","NVO","VERU","PFE","XBI","ABBV","NVOH","VIR","CRSP","BMY","MRK","BIIB","TEM","NVOC","AZN","BEAM","ELIS"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"2672075260","title":"GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672075260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672075260?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:16","pubTimestamp":1790856968,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827781.USD","LU0314104364.USD","LU2028103732.USD","LU0267386448.USD","KBWB","GSK.UK","LU0006306889.USD","BK4504","BK4127","IAI","BK4534","LU1244550221.USD","LU2089284900.SGD","LU1791710582.SGD","LU1244550494.USD","LU0158827948.USD","LU0098860793.USD","GSKH","IE00B3S45H60.SGD","BK4516","LU0234570918.USD","LU2023251221.USD","LU0882574139.USD","LU1548497426.USD","LU0390134368.USD","LU2487616109.SGD","LU0210528500.USD","LU0971096721.USD","LU0106261372.USD","BK4585","LU0528227936.USD","LU0795875086.SGD","LU0053666078.USD","LU2133065610.SGD","LU1668664300.SGD","LU2264538146.SGD","LU2089283258.USD","LU0225283273.USD","LU2347655156.SGD","LU0557290698.USD","LU0106831901.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1732800096.USD","LU1829250122.USD","LU2357305700.SGD","LU1064131342.USD","LU1791710400.SGD","GSK","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672878691","title":"GSK Slides Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672878691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672878691?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:08","pubTimestamp":1790784480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares shed 1.29% to GBP18.32 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index  falling 0.29% to 10,606.00.GSK PLC closed 19.72% short of its 52-week high of GBP22.82, which the company achieved on February 18th.Trading volume totaled 6.3 million, compared to the 50-day average of 6.6 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","GSK","BK4585","BK4588","GSK.UK","BK4007","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671778532","title":"European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2671778532","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671778532?lang=en_us&edition=fundamental","pubTime":"2026-09-30 23:19","pubTimestamp":1790781554,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.43% to 1,911.17 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and biopharmaceutical company DBV Technologies , which rose 5.2% and 3.4% respectively. They were followed by biopharmaceutical company Cellectis  and internet browser company Opera , which were up 2.4% and 1.3% respectively.The decliners from continental Europe were led by accommodations booking site trivago  and biopharmaceutical company argenx , which dropped 2.2% and 1.7% respectively. They were followed by healthcare tech company Royal Philips  and lender Banco Santander , which lost 1.2% and 1% respectively.The gainers from the UK were led by biopharmaceutical company NuCana  and software firm Endava , which advanced 7.9% and 4.9% respectively. They were followed by biotech firm Autolus Therapeutics  and biopharmace","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0648005311.SGD","BK4082","IE00B4R5TH58.HKD","AUTL","DBVT","IBB","LU0823416689.USD","LU0109394709.USD","SAN","SAN.AU","BK4134","BK4162","IEUR","WPP.AU","FMED","ARGX","MREO","TRIB","WPP","BK7142","TBXU","GSIB","LU1983260115.SGD","IE00BJJMRZ35.SGD","EPV","BK4023","IE0002141913.USD","PHG","AFG","BK4007","GSK","OPRA","BK4117","DAVA","GSK.UK","SQNS","BK4521","LU2324357040.USD","LU0390134368.USD","IE00BFTCPJ56.SGD","CLLS","DAVA.AU","BK4588","TRVG","IE00B2B36J28.USD","PUK","GSKH","LFGY","NCNA","LU0084288595.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671290809","title":"Jefferies Remains a Buy on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671290809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671290809?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:15","pubTimestamp":1790673326,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-glaxosmithkline-gsk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4585","LU1829250122.USD","GSKH","BK4588","GSK.UK","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}